Skip to content
Anirban Maitra· @Aiims1742 · X·· 2026-04-21Score60

#PANCREATICCANCER

Reading

KRAS / RAS targeting: from platform to Phase 3

daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%

Body

Are there genomic features in cystic precursor lesions of #PancreaticCancer that impact prognosis? Are there subsets where adjuvant therapy might be avoided post surgery even if a cancer derived from the cyst exists?
@peter_t_yu_md

@Perlmutter_CC
explains his findings at #AACR26

Heat 34 · 24 likes · 2 replies · 8 reposts

Source: Anirban Maitra · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org